Tech Stocks Rally in Asia-Pacific as Dollar Remains Resilient 
Apple Downgraded by Jefferies Amid Weak iPhone Sales and AI Concerns 
Mexico's Undervalued Equity Market Offers Long-Term Investment Potential 
Japan’s Nikkei Drops as Markets Await Key U.S. Inflation Data 
SoftBank Eyes Up to $25B OpenAI Investment Amid AI Boom 
Asian Currencies Steady as Markets Await Fed Rate Decision; Indian Rupee Hits New Record Low 
U.S. Banks Report Strong Q4 Profits Amid Investment Banking Surge 
South Korea to End Short-Selling Ban as Financial Market Uncertainty Persists 
Oil Prices Rise as Ukraine Targets Russian Energy Infrastructure 
Dollar Weakens Ahead of Expected Federal Reserve Rate Cut 
Wall Street Rebounds as Investors Eye Tariff Uncertainty, Jobs Report 
Ferrari Group to Launch IPO in Amsterdam, Targets Over $1 Billion Valuation 
Oil Prices Hold Steady as Ukraine Tensions and Fed Cut Expectations Support Market 
How the UK’s rollback of banking regulations could risk another financial crisis 
Gold Prices Rise as Markets Await Trump’s Policy Announcements 
While South Korean investors made Tesla a top pick among US-listed stocks with combined holdings of $9.7 billion as of Aug. 10, many had begun selling off shares in the world’s largest electric car maker in June while turning to vaccine-related stocks, including Moderna.
In June, South Korean investors sold $811 million worth of Tesla shares worthwhile purchasing $784.3 million, according to data compiled by the Korea Securities Depository.
It marked the first month since December 2019 in which there were more South Korean sellers than buyers of Tesla stock.
The trend continued in July with South Koreans selling Tesla shares amounting to $756.8 million, out sizing purchases of $716.1 million.
From Aug. 1 to 10, sales of Tesla stocks by South Koreans were equal to their purchases, both at $356.6 million.
South Koreans were also selling off Ark Innovation ETF, an exchange-traded fund product called popular for its 10 percent weighting in Tesla.
Since March, South Korean traders had divested $400 million worth of the flagship active ETF product from Ark Invest while purchasing just over $260 million during the same period.
South Korean investors purchased $430 million worth of Moderna stocks from July to Aug. 10, making it the fourth-largest US-listed stock after Tesla, Amazon, and Apple. Meanwhile, they sold $368 million worth of the said stock.
Consequently, Moderna’s stock price more than doubled over the last six months.
South Koreans also favored other vaccine stocks with Novavax and Pfizer making it in the top 50 list.
South Korean investors bought $32.1 billion worth of US-listed shares from June through Thursday while selling less than $30.4 billion.
